Safety and Efficacy of Bimekizumab in Patients With Moderate-to-Severe Hidradenitis Suppurativa: A Multicenter Retrospective Cohort Study.

Mansilla-Polo M, Pons-Benavent M, Fernández-Crehuet P, Vilarrasa E, Albanell-Fernández C, Morales-Tedone E, Rausell-Félix F, Alcalá-García R, Matellanes-Palacios M, Martín-Ezquerra G, Alfageme F, Ciudad-Blanco C, López-Villaescusa MT, Segura-Palacios JM, Pascual-Ramírez JC, Fernández-Díaz ML, Falkenhain-López D, García-Gil M, Agustí-Mejías A, No-Pérez N, Naranjo-Guerrero N, Estenaga-Pérez Á, García-Ruiz R, Mahiques-Santos L, Garbayo-Salmons P, Martorell A, Escutia-Muñoz B, Martín-Torregrosa D, Cuenca-Barrales C, Paniego CU, Botella-Estrada R, Molina-Leyva A, Spanish hidradenitis suppurativa group (GEHS)

Open source

DOI
10.1016/j.ad.2025.104531
Published
2026 Mar
Container
Actas dermo-sifiliograficas
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ad.2025.104531,
  title = {Safety and Efficacy of Bimekizumab in Patients With Moderate-to-Severe Hidradenitis Suppurativa: A Multicenter Retrospective Cohort Study.},
  author = {Mansilla-Polo M and Pons-Benavent M and Fernández-Crehuet P and Vilarrasa E and Albanell-Fernández C and Morales-Tedone E and Rausell-Félix F and Alcalá-García R and Matellanes-Palacios M and Martín-Ezquerra G and Alfageme F and Ciudad-Blanco C and López-Villaescusa MT and Segura-Palacios JM and Pascual-Ramírez JC and Fernández-Díaz ML and Falkenhain-López D and García-Gil M and Agustí-Mejías A and No-Pérez N and Naranjo-Guerrero N and Estenaga-Pérez Á and García-Ruiz R and Mahiques-Santos L and Garbayo-Salmons P and Martorell A and Escutia-Muñoz B and Martín-Torregrosa D and Cuenca-Barrales C and Paniego CU and Botella-Estrada R and Molina-Leyva A and Spanish hidradenitis suppurativa group (GEHS)},
  year = {2026},
  journal = {Actas dermo-sifiliograficas},
  doi = {10.1016/j.ad.2025.104531},
  url = {https://doi.org/10.1016/j.ad.2025.104531}
}

RIS

TY  - JOUR
TI  - Safety and Efficacy of Bimekizumab in Patients With Moderate-to-Severe Hidradenitis Suppurativa: A Multicenter Retrospective Cohort Study.
AU  - Mansilla-Polo M
AU  - Pons-Benavent M
AU  - Fernández-Crehuet P
AU  - Vilarrasa E
AU  - Albanell-Fernández C
AU  - Morales-Tedone E
AU  - Rausell-Félix F
AU  - Alcalá-García R
AU  - Matellanes-Palacios M
AU  - Martín-Ezquerra G
AU  - Alfageme F
AU  - Ciudad-Blanco C
AU  - López-Villaescusa MT
AU  - Segura-Palacios JM
AU  - Pascual-Ramírez JC
AU  - Fernández-Díaz ML
AU  - Falkenhain-López D
AU  - García-Gil M
AU  - Agustí-Mejías A
AU  - No-Pérez N
AU  - Naranjo-Guerrero N
AU  - Estenaga-Pérez Á
AU  - García-Ruiz R
AU  - Mahiques-Santos L
AU  - Garbayo-Salmons P
AU  - Martorell A
AU  - Escutia-Muñoz B
AU  - Martín-Torregrosa D
AU  - Cuenca-Barrales C
AU  - Paniego CU
AU  - Botella-Estrada R
AU  - Molina-Leyva A
AU  - Spanish hidradenitis suppurativa group (GEHS)
PY  - 2026
JO  - Actas dermo-sifiliograficas
DO  - 10.1016/j.ad.2025.104531
UR  - https://doi.org/10.1016/j.ad.2025.104531
ER  - 

APA

M, M., M, P., P, F., E, V., C, A., E, M., F, R., R, A., M, M., G, M., F, A., C, C., MT, L., JM, S., JC, P., ML, F., D, F., M, G., A, A., N, N., N, N., Á, E., R, G., L, M., P, G., A, M., B, E., D, M., C, C., CU, P., R, B., A, M., & (GEHS), S. H. S. G. (2026). Safety and Efficacy of Bimekizumab in Patients With Moderate-to-Severe Hidradenitis Suppurativa: A Multicenter Retrospective Cohort Study.. Actas dermo-sifiliograficas. https://doi.org/10.1016/j.ad.2025.104531

Source records